Steven D. Rubin, Director of Niagen Bioscience NAGE, has filed 5 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $19.4K. The latest trade was on 06/24.

SR

SR

Steven D. Rubin

Director

Company

Niagen Bioscience NAGE

First filing

23/01/31

Trades

29 trades

Buys / sales

5 / 1

12-month net buying

$19.5K

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Entera BioENTX	Open-market buy	02/12	02/17	5,000 sh	$1.49	$7,450	+50.0%
Entera BioENTX	Open-market buy	02/09	02/11	10,000 sh	$1.20	$12,000	No record
Red VioletRDVT	Open-market sale	25/03/19	25/03/21	10,000 sh	$38.93	$389,300	−6.6%
Opko HealthOPK	Open-market buy	24/01/05	24/01/05	10,000 sh	$0.87	$8,700	+0.2%
Opko HealthOPK	Open-market buy	23/11/10	23/11/13	10,000 sh	$1.30	$13,000	+0.2%
Niagen BioscienceNAGE	Open-market buy	23/05/25	23/05/30	7,000 sh	$1.46	$10,220	No record